Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Montagut

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cancer Letters|February 17, 2009
Targeting the RAF-MEK-ERK pathway in cancer therapyClara Montagut, Jeff Settleman
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|October 13, 2019
Dynamic Treatment Stratification Using ctDNAJoana Vidal, Alvaro Taus, Clara Montagut
Cancers|July 2, 2021
ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)Laura Masfarré, Joana Vidal, Concepción Fernández-Rodríguez, et al.
Leukemia & Lymphoma|September 17, 2004
Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomideClara Montagut, Francesc Bosch, Luís Villela, et al.
Journal of Chemotherapy (Florence, Italy)|June 5, 2015
Hypersensitivity reaction caused by folinic acid administration: a case report and literature reviewMarta Florit-Sureda, David Conde-Estévez, Joana Vidal, et al.
Frontiers in Pharmacology|May 7, 2024
Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding roadAlejandro Ríos-Hoyo, Xavier Monzonís, Joana Vidal, et al.
BJU International|November 10, 2006
Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agentsJoaquim Bellmunt, Clara Montagut, Santiago Albiol, et al.
Frontiers in Oncology|February 23, 2023
Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancerChiara Cremolini, Clara Montagut, Philippe Ronga, et al.
Expert Opinion on Biological Therapy|October 15, 2019
The role of PIGF blockade in the treatment of colorectal cancer: overcoming the pitfallsTeresa Macarulla, Clara Montagut, Francisco Javier Sánchez-Martin, et al.
Gynecologic Oncology|August 2, 2003
Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpusClara Montagut, Maribel Mármol, Victoria Rey, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cancer Letters|February 17, 2009
Targeting the RAF-MEK-ERK pathway in cancer therapyClara Montagut, Jeff Settleman
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|October 13, 2019
Dynamic Treatment Stratification Using ctDNAJoana Vidal, Alvaro Taus, Clara Montagut
Cancers|July 2, 2021
ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)Laura Masfarré, Joana Vidal, Concepción Fernández-Rodríguez, et al.
Leukemia & Lymphoma|September 17, 2004
Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomideClara Montagut, Francesc Bosch, Luís Villela, et al.
Journal of Chemotherapy (Florence, Italy)|June 5, 2015
Hypersensitivity reaction caused by folinic acid administration: a case report and literature reviewMarta Florit-Sureda, David Conde-Estévez, Joana Vidal, et al.
Frontiers in Pharmacology|May 7, 2024
Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding roadAlejandro Ríos-Hoyo, Xavier Monzonís, Joana Vidal, et al.
BJU International|November 10, 2006
Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agentsJoaquim Bellmunt, Clara Montagut, Santiago Albiol, et al.
Frontiers in Oncology|February 23, 2023
Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancerChiara Cremolini, Clara Montagut, Philippe Ronga, et al.
Expert Opinion on Biological Therapy|October 15, 2019
The role of PIGF blockade in the treatment of colorectal cancer: overcoming the pitfallsTeresa Macarulla, Clara Montagut, Francisco Javier Sánchez-Martin, et al.
Gynecologic Oncology|August 2, 2003
Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpusClara Montagut, Maribel Mármol, Victoria Rey, et al.
Pageof 8